Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma

O'Reilly, Eileen M. ; Lee, Jonathan W. ; Lowery, Maeve A. ; Capanu, Marinela ; Stadler, Zsofia K. ; Moore, Malcolm J. ; Dhani, Neesha ; Kindler, Hedy L. ; Estrella, Hayley ; Maynard, Hannah ; Golan, Talia ; Segal, Amiel ; Salo‐Mullen, Erin E. ; Yu, Kenneth H. ; Epstein, Andrew S. ; Segal, Michal ; Brenner, Robin ; Do, Richard K. ; Chen, Alice P. ; Tang, Laura H. ; Kelsen, David P.

Cancer, 2018-04, Vol.124 (7), p.1374-1382 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível